1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Biochemical Diagnosis 1.2.3 Immune Diagnosis 1.2.4 Molecular Diagnosis 1.2.5 Microbiological Diagnosis 1.2.6 Urine Diagnosis 1.2.7 Coagulation Diagnosis 1.2.8 Other 1.3 Market by Application 1.3.1 Global IVD Infectious Disease Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Personal 1.3.3 Commercial 1.3.4 Academic 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global IVD Infectious Disease Market Perspective (2016-2027) 2.2 IVD Infectious Disease Growth Trends by Regions 2.2.1 IVD Infectious Disease Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 IVD Infectious Disease Historic Market Share by Regions (2016-2021) 2.2.3 IVD Infectious Disease Forecasted Market Size by Regions (2022-2027) 2.3 IVD Infectious Disease Industry Dynamic 2.3.1 IVD Infectious Disease Market Trends 2.3.2 IVD Infectious Disease Market Drivers 2.3.3 IVD Infectious Disease Market Challenges 2.3.4 IVD Infectious Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top IVD Infectious Disease Players by Revenue 3.1.1 Global Top IVD Infectious Disease Players by Revenue (2016-2021) 3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2016-2021) 3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by IVD Infectious Disease Revenue 3.4 Global IVD Infectious Disease Market Concentration Ratio 3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2020 3.5 IVD Infectious Disease Key Players Head office and Area Served 3.6 Key Players IVD Infectious Disease Product Solution and Service 3.7 Date of Enter into IVD Infectious Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 IVD Infectious Disease Breakdown Data by Type 4.1 Global IVD Infectious Disease Historic Market Size by Type (2016-2021) 4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2022-2027) 5 IVD Infectious Disease Breakdown Data by Application 5.1 Global IVD Infectious Disease Historic Market Size by Application (2016-2021) 5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America IVD Infectious Disease Market Size (2016-2027) 6.2 North America IVD Infectious Disease Market Size by Type 6.2.1 North America IVD Infectious Disease Market Size by Type (2016-2021) 6.2.2 North America IVD Infectious Disease Market Size by Type (2022-2027) 6.2.3 North America IVD Infectious Disease Market Size by Type (2016-2027) 6.3 North America IVD Infectious Disease Market Size by Application 6.3.1 North America IVD Infectious Disease Market Size by Application (2016-2021) 6.3.2 North America IVD Infectious Disease Market Size by Application (2022-2027) 6.3.3 North America IVD Infectious Disease Market Size by Application (2016-2027) 6.4 North America IVD Infectious Disease Market Size by Country 6.4.1 North America IVD Infectious Disease Market Size by Country (2016-2021) 6.4.2 North America IVD Infectious Disease Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe IVD Infectious Disease Market Size (2016-2027) 7.2 Europe IVD Infectious Disease Market Size by Type 7.2.1 Europe IVD Infectious Disease Market Size by Type (2016-2021) 7.2.2 Europe IVD Infectious Disease Market Size by Type (2022-2027) 7.2.3 Europe IVD Infectious Disease Market Size by Type (2016-2027) 7.3 Europe IVD Infectious Disease Market Size by Application 7.3.1 Europe IVD Infectious Disease Market Size by Application (2016-2021) 7.3.2 Europe IVD Infectious Disease Market Size by Application (2022-2027) 7.3.3 Europe IVD Infectious Disease Market Size by Application (2016-2027) 7.4 Europe IVD Infectious Disease Market Size by Country 7.4.1 Europe IVD Infectious Disease Market Size by Country (2016-2021) 7.4.2 Europe IVD Infectious Disease Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific IVD Infectious Disease Market Size (2016-2027) 8.2 Asia-Pacific IVD Infectious Disease Market Size by Type 8.2.1 Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2021) 8.2.2 Asia-Pacific IVD Infectious Disease Market Size by Type (2022-2027) 8.2.3 Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2027) 8.3 Asia-Pacific IVD Infectious Disease Market Size by Application 8.3.1 Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2021) 8.3.2 Asia-Pacific IVD Infectious Disease Market Size by Application (2022-2027) 8.3.3 Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2027) 8.4 Asia-Pacific IVD Infectious Disease Market Size by Region 8.4.1 Asia-Pacific IVD Infectious Disease Market Size by Region (2016-2021) 8.4.2 Asia-Pacific IVD Infectious Disease Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America IVD Infectious Disease Market Size (2016-2027) 9.2 Latin America IVD Infectious Disease Market Size by Type 9.2.1 Latin America IVD Infectious Disease Market Size by Type (2016-2021) 9.2.2 Latin America IVD Infectious Disease Market Size by Type (2022-2027) 9.2.3 Latin America IVD Infectious Disease Market Size by Type (2016-2027) 9.3 Latin America IVD Infectious Disease Market Size by Application 9.3.1 Latin America IVD Infectious Disease Market Size by Application (2016-2021) 9.3.2 Latin America IVD Infectious Disease Market Size by Application (2022-2027) 9.3.3 Latin America IVD Infectious Disease Market Size by Application (2016-2027) 9.4 Latin America IVD Infectious Disease Market Size by Country 9.4.1 Latin America IVD Infectious Disease Market Size by Country (2016-2021) 9.4.2 Latin America IVD Infectious Disease Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa IVD Infectious Disease Market Size (2016-2027) 10.2 Middle East & Africa IVD Infectious Disease Market Size by Type 10.2.1 Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2021) 10.2.2 Middle East & Africa IVD Infectious Disease Market Size by Type (2022-2027) 10.2.3 Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2027) 10.3 Middle East & Africa IVD Infectious Disease Market Size by Application 10.3.1 Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2021) 10.3.2 Middle East & Africa IVD Infectious Disease Market Size by Application (2022-2027) 10.3.3 Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2027) 10.4 Middle East & Africa IVD Infectious Disease Market Size by Country 10.4.1 Middle East & Africa IVD Infectious Disease Market Size by Country (2016-2021) 10.4.2 Middle East & Africa IVD Infectious Disease Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche Diagnostics 11.1.1 Roche Diagnostics Company Details 11.1.2 Roche Diagnostics Business Overview 11.1.3 Roche Diagnostics IVD Infectious Disease Introduction 11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2016-2021) 11.1.5 Roche Diagnostics Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Details 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories IVD Infectious Disease Introduction 11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2016-2021) 11.2.5 Abbott Laboratories Recent Development 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott IVD Infectious Disease Introduction 11.3.4 Abbott Revenue in IVD Infectious Disease Business (2016-2021) 11.3.5 Abbott Recent Development 11.4 Gen-Probe 11.4.1 Gen-Probe Company Details 11.4.2 Gen-Probe Business Overview 11.4.3 Gen-Probe IVD Infectious Disease Introduction 11.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2016-2021) 11.4.5 Gen-Probe Recent Development 11.5 Becton Dickinson (BD) 11.5.1 Becton Dickinson (BD) Company Details 11.5.2 Becton Dickinson (BD) Business Overview 11.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction 11.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2016-2021) 11.5.5 Becton Dickinson (BD) Recent Development 11.6 Bio-Rad Laboratories 11.6.1 Bio-Rad Laboratories Company Details 11.6.2 Bio-Rad Laboratories Business Overview 11.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction 11.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2016-2021) 11.6.5 Bio-Rad Laboratories Recent Development 11.7 Siemens Healthcare 11.7.1 Siemens Healthcare Company Details 11.7.2 Siemens Healthcare Business Overview 11.7.3 Siemens Healthcare IVD Infectious Disease Introduction 11.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2016-2021) 11.7.5 Siemens Healthcare Recent Development 11.8 Biomérieux 11.8.1 Biomérieux Company Details 11.8.2 Biomérieux Business Overview 11.8.3 Biomérieux IVD Infectious Disease Introduction 11.8.4 Biomérieux Revenue in IVD Infectious Disease Business (2016-2021) 11.8.5 Biomérieux Recent Development 11.9 Danaher 11.9.1 Danaher Company Details 11.9.2 Danaher Business Overview 11.9.3 Danaher IVD Infectious Disease Introduction 11.9.4 Danaher Revenue in IVD Infectious Disease Business (2016-2021) 11.9.5 Danaher Recent Development 11.10 Thermo Fisher 11.10.1 Thermo Fisher Company Details 11.10.2 Thermo Fisher Business Overview 11.10.3 Thermo Fisher IVD Infectious Disease Introduction 11.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2016-2021) 11.10.5 Thermo Fisher Recent Development 11.11 Sysmex 11.11.1 Sysmex Company Details 11.11.2 Sysmex Business Overview 11.11.3 Sysmex IVD Infectious Disease Introduction 11.11.4 Sysmex Revenue in IVD Infectious Disease Business (2016-2021) 11.11.5 Sysmex Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Biochemical Diagnosis Table 3. Key Players of Immune Diagnosis Table 4. Key Players of Molecular Diagnosis Table 5. Key Players of Microbiological Diagnosis Table 6. Key Players of Urine Diagnosis Table 7. Key Players of Coagulation Diagnosis Table 8. Key Players of Other Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global IVD Infectious Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global IVD Infectious Disease Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global IVD Infectious Disease Market Share by Regions (2016-2021) Table 13. Global IVD Infectious Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global IVD Infectious Disease Market Share by Regions (2022-2027) Table 15. IVD Infectious Disease Market Trends Table 16. IVD Infectious Disease Market Drivers Table 17. IVD Infectious Disease Market Challenges Table 18. IVD Infectious Disease Market Restraints Table 19. Global IVD Infectious Disease Revenue by Players (2016-2021) & (US$ Million) Table 20. Global IVD Infectious Disease Market Share by Players (2016-2021) Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2020) Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players IVD Infectious Disease Product Solution and Service Table 26. Date of Enter into IVD Infectious Disease Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2016-2021) Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global IVD Infectious Disease Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2016-2021) Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 37. North America IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million) Table 38. North America IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million) Table 39. North America IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million) Table 40. North America IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million) Table 41. North America IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 43. Europe IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million) Table 45. Europe IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific IVD Infectious Disease Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific IVD Infectious Disease Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million) Table 66. Roche Diagnostics Company Details Table 67. Roche Diagnostics Business Overview Table 68. Roche Diagnostics IVD Infectious Disease Product Table 69. Roche Diagnostics Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 70. Roche Diagnostics Recent Development Table 71. Abbott Laboratories Company Details Table 72. Abbott Laboratories Business Overview Table 73. Abbott Laboratories IVD Infectious Disease Product Table 74. Abbott Laboratories Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 75. Abbott Laboratories Recent Development Table 76. Abbott Company Details Table 77. Abbott Business Overview Table 78. Abbott IVD Infectious Disease Product Table 79. Abbott Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 80. Abbott Recent Development Table 81. Gen-Probe Company Details Table 82. Gen-Probe Business Overview Table 83. Gen-Probe IVD Infectious Disease Product Table 84. Gen-Probe Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 85. Gen-Probe Recent Development Table 86. Becton Dickinson (BD) Company Details Table 87. Becton Dickinson (BD) Business Overview Table 88. Becton Dickinson (BD) IVD Infectious Disease Product Table 89. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 90. Becton Dickinson (BD) Recent Development Table 91. Bio-Rad Laboratories Company Details Table 92. Bio-Rad Laboratories Business Overview Table 93. Bio-Rad Laboratories IVD Infectious Disease Product Table 94. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 95. Bio-Rad Laboratories Recent Development Table 96. Siemens Healthcare Company Details Table 97. Siemens Healthcare Business Overview Table 98. Siemens Healthcare IVD Infectious Disease Product Table 99. Siemens Healthcare Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 100. Siemens Healthcare Recent Development Table 101. Biomérieux Company Details Table 102. Biomérieux Business Overview Table 103. Biomérieux Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 104. Biomérieux Recent Development Table 105. Danaher Company Details Table 106. Danaher Business Overview Table 107. Danaher IVD Infectious Disease Product Table 108. Danaher Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 109. Danaher Recent Development Table 110. Thermo Fisher Company Details Table 111. Thermo Fisher Business Overview Table 112. Thermo Fisher IVD Infectious Disease Product Table 113. Thermo Fisher Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 114. Thermo Fisher Recent Development Table 115. Sysmex Company Details Table 116. Sysmex Business Overview Table 117. Sysmex IVD Infectious Disease Product Table 118. Sysmex Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million) Table 119. Sysmex Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global IVD Infectious Disease Market Share by Type: 2020 VS 2027 Figure 2. Biochemical Diagnosis Features Figure 3. Immune Diagnosis Features Figure 4. Molecular Diagnosis Features Figure 5. Microbiological Diagnosis Features Figure 6. Urine Diagnosis Features Figure 7. Coagulation Diagnosis Features Figure 8. Other Features Figure 9. Global IVD Infectious Disease Market Share by Application: 2020 VS 2027 Figure 10. Personal Case Studies Figure 11. Commercial Case Studies Figure 12. Academic Case Studies Figure 13. Other Case Studies Figure 14. IVD Infectious Disease Report Years Considered Figure 15. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global IVD Infectious Disease Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global IVD Infectious Disease Market Share by Regions: 2020 VS 2027 Figure 18. Global IVD Infectious Disease Market Share by Regions (2022-2027) Figure 19. Global IVD Infectious Disease Market Share by Players in 2020 Figure 20. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2020 Figure 21. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2020 Figure 22. Global IVD Infectious Disease Revenue Market Share by Type (2016-2021) Figure 23. Global IVD Infectious Disease Revenue Market Share by Type (2022-2027) Figure 24. North America IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America IVD Infectious Disease Market Share by Type (2016-2027) Figure 26. North America IVD Infectious Disease Market Share by Application (2016-2027) Figure 27. North America IVD Infectious Disease Market Share by Country (2016-2027) Figure 28. United States IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe IVD Infectious Disease Market Share by Type (2016-2027) Figure 32. Europe IVD Infectious Disease Market Share by Application (2016-2027) Figure 33. Europe IVD Infectious Disease Market Share by Country (2016-2027) Figure 34. Germany IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific IVD Infectious Disease Market Share by Type (2016-2027) Figure 42. Asia-Pacific IVD Infectious Disease Market Share by Application (2016-2027) Figure 43. Asia-Pacific IVD Infectious Disease Market Share by Region (2016-2027) Figure 44. China IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America IVD Infectious Disease Market Share by Type (2016-2027) Figure 52. Latin America IVD Infectious Disease Market Share by Application (2016-2027) Figure 53. Latin America IVD Infectious Disease Market Share by Country (2016-2027) Figure 54. Mexico IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa IVD Infectious Disease Market Share by Type (2016-2027) Figure 58. Middle East & Africa IVD Infectious Disease Market Share by Application (2016-2027) Figure 59. Middle East & Africa IVD Infectious Disease Market Share by Country (2016-2027) Figure 60. Turkey IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 64. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 65. Abbott Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 66. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 67. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 68. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 69. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 70. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 71. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 72. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 73. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Roche Diagnostics Abbott Laboratories Abbott Gen-Probe Becton Dickinson (BD) Bio-Rad Laboratories Siemens Healthcare Biomérieux Danaher Thermo Fisher Sysmex